Menu

Comera Life Sciences Holdings, Inc. CMRA

Full chart Compare
Set alert

Price alert · CMRA

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 6, 2026, 4:00 PM EST

0.0001 Day range 0.0001
0.0001 52-week range 0.0001
YTD
0.00%
1 year
0.00%

Revenue & Expenses

Revenue → Gross Profit: $422.71KGross Profit → Expenses: $422.71KRevenue → Cost of Revenue: $210.39KExpenses → Selling, General & Admin: $10.65MExpenses → Research & Development: $1.74MExpenses → Interest Expense: $20.39KExpenses → Other Expenses: $6.01MNet Loss → Expenses: $18.00MGross Profit$422.71KNet Loss$18.00MCost of Revenue$210.39KExpenses$18.43MSelling, General & Admin$10.65MResearch & Development$1.74MInterest Expense$20.39KOther Expenses$6.01MRevenue$633.10K

Latest period ending Dec 31, 2022 · select a line to chart its full history

CMRA annual income statement
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
633.10K319.83K442.92K
422.71K158.82K338.51K
-11.97M-5.54M-2.13M
-18.00M-5.45M-2.13M
-1.76-1.81-0.19
CMRA annual balance sheet
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
1.95M6.51M180.43K
3.73M7.42M545.88K
5.46M1.25M393.96K
775.05K323.06K160.59K
-6.25M-14.69M151.91K
CMRA annual cash flow
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-9.77M-3.76M-1.80M
-28.61K-142.01K-12.37K
5.24M10.28M1.55M
-28.61K-142.01K-12.37K
-4.56M6.38M-264.14K